Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirenteli
... Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Kits, Chemical & reagents, and Consumables), Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies)
... (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies) The global antibody testing market was valued at US$ million 7,260.00 in 2021 and is projected to reach US$ 11,578.47 million by 2028; it is ... Read More
-
Global Autoimmune Disease Diagnostics Market Size & Share to 2027
... Tests, Autoantibodies & Immunologic Test, and Others), By Disease, By End User,By Region and Forecast till 2027 Global Autoimmune Disease Diagnostics Market Autoimmune disease is the defined as the immune system attacks on healthy cells ... Read More
-
Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027
... market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. The global anti-inflammatory ... Read More
-
Global Long-acting Monoclonal Antibodies Market Size Study, By Source Type (Murine, Chimeric, Humanized, Human) By Indication (Cancer, Autoimmune Disease, Inflammatory Disease, Infectious Disease, Others) By End-User (Hospital Pharmacies, Drug Store, Retail Pharmacies, E-Commerce) and regional forecasts 2022-2028
... forecasts 2022-2028 Global Long-acting Monoclonal Antibodies Market is valued approximately USD xx Billion in 2021 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2022-2028. ... Read More
-
Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028
... Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028 Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The South & Central America monoclonal antibodies market is expected to reach US$ 10,847.3 million by ... Read More
-
Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Middle East & Africa monoclonal antibodies market is expected to reach US$ 5,741.1 million by ... Read More
-
Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More
-
Global Stem Cell Therapy Market Size study, By Cell Source (Adipose tissue-derived MSCs (mesenchymal stem cells), Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, Other Cell Sources), By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other), and Regional Forecasts 2022-2028
... By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other), and Regional Forecasts 2022-2028 Global Stem Cell Therapy Market is valued approximately USD 160.52 million in 2021 ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
Middle East and Africa Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... & antibody-like proteins, and Biosimilar antibody products) The Middle East and Africa (MEA) next-generation antibody market is expected to reach US$ 450.75 million by 2028 from US$ 222.59 million in 2021. It is estimated to ... Read More
-
North America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The North America next-generation antibody market is expected to reach US$ 5,428.80 million by 2028 from US$ 2,457.09 million in 2021. It is estimated to grow at a CAGR of ... Read More
-
Europe Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Europe monoclonal antibodies market is expected to reach US$ 61,019.8 million by 2028 from US$ 29,254.3 million in ... Read More
-
North America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The North America monoclonal antibodies market is expected to grow from US$ 54,629.4 million in 2021 to US$ ... Read More
-
Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... and Biosimilar antibody products) The Europe next-generation antibody market is expected to reach US$ 3,162.30 million by 2028 from US$ 1,455.32 million in 2021. It is estimated to grow at a CAGR of 11.7% from ... Read More
-
South and Central America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... & antibody-like proteins, and Biosimilar antibody products) The South and Central America (SCAM) next-generation antibody market are expected to reach US$ 695.60 million by 2028 from US$ 333.92 million in 2021. It is estimated to ... Read More
-
Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The Asia Pacific (APAC) next-generation antibody market is expected to reach US$ 2,312.68 million by 2028 from US$ 999.49 million in 2021. It is estimated to grow at a CAGR ... Read More
-
Lupus Therapeutic Market, by Disease Type (Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, and Neonatal Lupus), by Treatment Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Biologics, Antimalarial Drugs, Corticosteroids, and Others {Disease-Modifying Anti-Rheumatic Drugs, Anticoagulants, among others}), by Route of Administration (Oral, Subcutaneous, Intravenous, and Others {Intramuscular, Intradermal, among others}, by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others {Homecare, Specialty Centre, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Anticoagulants, among others}), by Route of Administration (Oral, Subcutaneous, Intravenous, and Others {Intramuscular, Intradermal, among others}, by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others {Homecare, Specialty Centre, among others}), and by Region (North ... Read More
-
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028
... Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is valued approximately USD ... Read More
-
Lupus Nephritis - Epidemiology Forecast - 2032
... Italy, France, and United Kingdom), and Japan. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2019-2032 Lupus Nephritis Understanding The DelveInsight’s Lupus Nephritis epidemiology report gives ... Read More
-
In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infectious Diseases, Oncology, Metabolic Diseases, Autoimmune Diseases, and Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 In Vitro Diagnostics Market – Scope of Report TMR’s report ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global blood plasma derivatives market was valued at ... Read More
Research Assistance
